Hi-Clearance Inc. (TPEX:1788)
Taiwan · Delayed Price · Currency is TWD 136.50
-0.50 (-0.36%)
At close: Mar 27, 2026
Hi-Clearance Revenue
In the year 2025, Hi-Clearance had annual revenue of 4.28B TWD with 5.04% growth. Hi-Clearance had revenue of 1.09B in the quarter ending December 31, 2025, with 8.99% growth.
Revenue
4.28B
Revenue Growth
+5.04%
P/S Ratio
1.42
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.28B | 205.42M | 5.04% |
| Dec 31, 2024 | 4.07B | 177.03M | 4.54% |
| Dec 31, 2023 | 3.90B | -793.91M | -16.93% |
| Dec 31, 2022 | 4.69B | 1.01B | 27.30% |
| Dec 31, 2021 | 3.68B | 252.04M | 7.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| United Orthopedic | 5.66B |
| TaiDoc Technology | 4.20B |
| Wellell | 2.40B |
| InnoCare Optoelectronics | 2.29B |
| Dynamic Medical Technologies | 1.39B |
| WeLeader Biomedical | 1.11B |
| A Plus Biotechnology | 835.89M |
| Delta Asia International | 694.15M |